Malignant Neoplasm of the Endometrium B045
Current RMA Instruments:
| Reasonable Hypothesis SOP | 11 of 2016 |
| Balance of Probabilities SOP | 12 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 182.0
- ICD-10-AM Codes: C54.1
Brief description
This SOP covers cancer of the lining of the uterus.
Confirming the diagnosis
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
Diagnoses covered by SOP
- Adenoacanthoma of the endometrium
- Adenocarcinoma of the endometrium
- Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
- Carcinoma-in-situ of the endometrium
- Carcinosarcoma of the endometrium
- Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
- Hodgkin's lymphoma of the endometrium*
- Leiomyoma (fibroid) of the uterus#
- Malignant neoplasm of the cervix*
- non-Hodgkin's lymphoma of the endometrium*
- soft tissue sarcoma of the endometrium*
*another SOP applies, # nonSOP
Clinical onset
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
Clinical worsening
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-endometrium-b045-c541
Rulebase for malignant neoplasm of the endometrium
<h3><strong>Current RMA Instruments:</strong></h3><table border="1" cellpadding="1" cellspacing="1"><tbody><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2016/011.pdf" target="_blank">Reasonable Hypothesis SOP</a></address></td><td>11 of 2016</td></tr><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2016/012.pdf" target="_blank">Balance of Probabilities SOP </a></address></td><td>12 of 2016</td></tr></tbody></table><h5>Changes from previous Instruments:</h5><p><drupal-media data-entity-type="media" data-entity-uuid="e3310479-13ad-4567-8ffe-c9b23bd34394" data-view-mode="wysiwyg"></drupal-media></p><h5> ICD Coding:</h5><ul><li>ICD-9-CM Codes: 182.0</li><li>ICD-10-AM Codes: C54.1</li></ul><h5>Brief description</h5><p>This SOP covers cancer of the lining of the uterus.</p><h5>Confirming the diagnosis</h5><p>Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.</p><p>The relevant medical specialist is a gynaecologist or gynaecological oncologist.</p><h5>Diagnoses covered by SOP</h5><ul><li>Adenoacanthoma of the endometrium</li><li>Adenocarcinoma of the endometrium</li><li>Adenosquamous, clear cell and papillary serous carcinoma of the endometrium</li><li>Carcinoma-in-situ of the endometrium</li><li>Carcinosarcoma of the endometrium</li><li>Malignant mesodermal mixed tumour of the endometrium</li></ul><h5>Conditions excluded from SOP</h5><ul><li>Hodgkin's lymphoma of the endometrium*</li><li>Leiomyoma (fibroid) of the uterus<span><sup>#</sup></span></li><li>Malignant neoplasm of the cervix*</li><li>non-Hodgkin's lymphoma of the endometrium*</li><li>soft tissue sarcoma of the endometrium*</li></ul><p> <span><sup>*</sup></span>another SOP applies, <span><sup># </sup></span>nonSOP</p><h5>Clinical onset</h5><p>Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.</p><h5>Clinical worsening</h5><p>The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.</p><p> </p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/rulebase-malignant-neoplasm-endometrium
A course of therapeutic radiation involving the pelvic organs
Current RMA Instruments:
| Reasonable Hypothesis SOP | 11 of 2016 |
| Balance of Probabilities SOP | 12 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 182.0
- ICD-10-AM Codes: C54.1
Brief description
This SOP covers cancer of the lining of the uterus.
Confirming the diagnosis
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
Diagnoses covered by SOP
- Adenoacanthoma of the endometrium
- Adenocarcinoma of the endometrium
- Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
- Carcinoma-in-situ of the endometrium
- Carcinosarcoma of the endometrium
- Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
- Hodgkin's lymphoma of the endometrium*
- Leiomyoma (fibroid) of the uterus#
- Malignant neoplasm of the cervix*
- non-Hodgkin's lymphoma of the endometrium*
- soft tissue sarcoma of the endometrium*
*another SOP applies, # nonSOP
Clinical onset
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
Clinical worsening
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-endometrium-b045-c541/rulebase-malignant-neoplasm-endometrium/course-therapeutic-radiation-involving-pelvic-organs
Being nulliparous
Current RMA Instruments:
| Reasonable Hypothesis SOP | 11 of 2016 |
| Balance of Probabilities SOP | 12 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 182.0
- ICD-10-AM Codes: C54.1
Brief description
This SOP covers cancer of the lining of the uterus.
Confirming the diagnosis
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
Diagnoses covered by SOP
- Adenoacanthoma of the endometrium
- Adenocarcinoma of the endometrium
- Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
- Carcinoma-in-situ of the endometrium
- Carcinosarcoma of the endometrium
- Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
- Hodgkin's lymphoma of the endometrium*
- Leiomyoma (fibroid) of the uterus#
- Malignant neoplasm of the cervix*
- non-Hodgkin's lymphoma of the endometrium*
- soft tissue sarcoma of the endometrium*
*another SOP applies, # nonSOP
Clinical onset
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
Clinical worsening
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-endometrium-b045-c541/rulebase-malignant-neoplasm-endometrium/being-nulliparous
Hormonal replacement therapy
Current RMA Instruments:
| Reasonable Hypothesis SOP | 11 of 2016 |
| Balance of Probabilities SOP | 12 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 182.0
- ICD-10-AM Codes: C54.1
Brief description
This SOP covers cancer of the lining of the uterus.
Confirming the diagnosis
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
Diagnoses covered by SOP
- Adenoacanthoma of the endometrium
- Adenocarcinoma of the endometrium
- Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
- Carcinoma-in-situ of the endometrium
- Carcinosarcoma of the endometrium
- Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
- Hodgkin's lymphoma of the endometrium*
- Leiomyoma (fibroid) of the uterus#
- Malignant neoplasm of the cervix*
- non-Hodgkin's lymphoma of the endometrium*
- soft tissue sarcoma of the endometrium*
*another SOP applies, # nonSOP
Clinical onset
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
Clinical worsening
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-endometrium-b045-c541/rulebase-malignant-neoplasm-endometrium/hormonal-replacement-therapy
No appropriate clinical management for malignant neoplasm of endometrium
Current RMA Instruments:
| Reasonable Hypothesis SOP | 11 of 2016 |
| Balance of Probabilities SOP | 12 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 182.0
- ICD-10-AM Codes: C54.1
Brief description
This SOP covers cancer of the lining of the uterus.
Confirming the diagnosis
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
Diagnoses covered by SOP
- Adenoacanthoma of the endometrium
- Adenocarcinoma of the endometrium
- Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
- Carcinoma-in-situ of the endometrium
- Carcinosarcoma of the endometrium
- Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
- Hodgkin's lymphoma of the endometrium*
- Leiomyoma (fibroid) of the uterus#
- Malignant neoplasm of the cervix*
- non-Hodgkin's lymphoma of the endometrium*
- soft tissue sarcoma of the endometrium*
*another SOP applies, # nonSOP
Clinical onset
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
Clinical worsening
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-endometrium-b045-c541/rulebase-malignant-neoplasm-endometrium/no-appropriate-clinical-management-malignant-neoplasm-endometrium
Obesity
Current RMA Instruments:
| Reasonable Hypothesis SOP | 11 of 2016 |
| Balance of Probabilities SOP | 12 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 182.0
- ICD-10-AM Codes: C54.1
Brief description
This SOP covers cancer of the lining of the uterus.
Confirming the diagnosis
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
Diagnoses covered by SOP
- Adenoacanthoma of the endometrium
- Adenocarcinoma of the endometrium
- Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
- Carcinoma-in-situ of the endometrium
- Carcinosarcoma of the endometrium
- Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
- Hodgkin's lymphoma of the endometrium*
- Leiomyoma (fibroid) of the uterus#
- Malignant neoplasm of the cervix*
- non-Hodgkin's lymphoma of the endometrium*
- soft tissue sarcoma of the endometrium*
*another SOP applies, # nonSOP
Clinical onset
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
Clinical worsening
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-endometrium-b045-c541/rulebase-malignant-neoplasm-endometrium/obesity
Stein-Leventhal syndrome
Current RMA Instruments:
| Reasonable Hypothesis SOP | 11 of 2016 |
| Balance of Probabilities SOP | 12 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 182.0
- ICD-10-AM Codes: C54.1
Brief description
This SOP covers cancer of the lining of the uterus.
Confirming the diagnosis
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
Diagnoses covered by SOP
- Adenoacanthoma of the endometrium
- Adenocarcinoma of the endometrium
- Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
- Carcinoma-in-situ of the endometrium
- Carcinosarcoma of the endometrium
- Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
- Hodgkin's lymphoma of the endometrium*
- Leiomyoma (fibroid) of the uterus#
- Malignant neoplasm of the cervix*
- non-Hodgkin's lymphoma of the endometrium*
- soft tissue sarcoma of the endometrium*
*another SOP applies, # nonSOP
Clinical onset
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
Clinical worsening
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-endometrium-b045-c541/rulebase-malignant-neoplasm-endometrium/stein-leventhal-syndrome
Treatment with tamoxifen
Current RMA Instruments:
| Reasonable Hypothesis SOP | 11 of 2016 |
| Balance of Probabilities SOP | 12 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 182.0
- ICD-10-AM Codes: C54.1
Brief description
This SOP covers cancer of the lining of the uterus.
Confirming the diagnosis
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
Diagnoses covered by SOP
- Adenoacanthoma of the endometrium
- Adenocarcinoma of the endometrium
- Adenosquamous, clear cell and papillary serous carcinoma of the endometrium
- Carcinoma-in-situ of the endometrium
- Carcinosarcoma of the endometrium
- Malignant mesodermal mixed tumour of the endometrium
Conditions excluded from SOP
- Hodgkin's lymphoma of the endometrium*
- Leiomyoma (fibroid) of the uterus#
- Malignant neoplasm of the cervix*
- non-Hodgkin's lymphoma of the endometrium*
- soft tissue sarcoma of the endometrium*
*another SOP applies, # nonSOP
Clinical onset
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
Clinical worsening
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-endometrium-b045-c541/rulebase-malignant-neoplasm-endometrium/treatment-tamoxifen